WeightWatchers has entered into a definitive agreement to acquire Sequence, a subscription telehealth platform offering access to healthcare providers specialising in chronic weight management. Sequence seamlessly integrates the patient and clinician experience for ongoing, clinical care and medication management while providing high-touch support in navigating the insurance approval process.
“WeightWatchers’ nutrition and behaviour-change program can provide the support needed to help people build liveable healthy habits for the long term and manage the dietary-induced side effects often felt while taking chronic weight management medications, such as glucagon-like peptide-1s (GLP-1s),” said Dr. Gary Foster, PhD, Chief Scientific Officer of WeightWatchers. “As we build out our clinical weight management pathway, we will be learning and likely tailoring our nutrition program for this distinct member journey. We know weight management isn’t one-size-fits-all and clinical interventions are not medically or otherwise appropriate for everyone, which is why we remain committed to all pathways.”
Since its launch in late 2021, Sequence has quickly grown into an approximately $25 million annual revenue run-rate business serving approximately 24,000 members across the U.S. as of February 2023. Sequence has a highly efficient operating model and recently turned cash flow positive, while continuing to drive strong growth primarily through word of mouth.
Sequence members have highlighted the benefits of its service, including support in navigating the insurance approval process and the quality care they receive from clinicians.
“Pairing behaviour change with medically appropriate clinical solutions is more powerful and more sustainable than clinical alone,” said Rémi Cossart, CEO and Co-Founder of Sequence.
“With our science-backed lifestyle program and Sequence’s tech platform, this is an unmatched opportunity for us to create an integrated product offering. We want to ensure we have the best programs and experiences for everyone. Together, we will provide impactful, holistic solutions for people living with overweight or obesity,” said Sima Sistani, CEO of WeightWatchers.
Click here to read the original news story.
Looking for expert insights in Virtual Care Delivery? Join the HealthXL Masterclass on ‘Current State of Routes to Market in Digital Health’ on 28th March. Click here to Request to Join.